Literature DB >> 10712384

Regulation of cdk2 activity in endothelial cells that are inhibited from growth by cell contact.

D Chen1, K Walsh, J Wang.   

Abstract

Endothelial cells (ECs) are quiescent in normal blood vessels but undergo rapid bursts of proliferation after vascular injury and during angiogenesis. Here we show that the activity of cyclin-dependent kinase-2 (cdk2), a key regulator of the G1 and S phases of the cell cycle, is expressed at high levels in proliferating ECs but at low levels in ECs that are contact-inhibited for growth. Despite these differences in kinase activity, the protein levels of cdk2 and 1 of its activating subunits, cyclin E, are not modulated by these different growth conditions. The cdk inhibitor p27 is highly expressed in contact-inhibited but not proliferating ECs, whereas the level of cyclin A protein is preferentially expressed in proliferating ECs. p27 protein was detected in immunoprecipitable complexes with cdk2 or cyclin E in cultures that were contact-inhibited for growth. The functional significance of the p27 induction was indicated by the detection of a heat-stable cdk2 inhibitory activity that was induced by endothelial cell-cell contact and could be immunodepleted with anti-p27 antibodies. In a confluent EC monolayer, cdk2 kinase activity was activated by a scraping injury that led to cell migration and proliferation. The injury-induced activation of cdk2 coincided with the downregulation of p27 and the induction of cyclin A. These data demonstrate that p27 is induced in confluent cultures of ECs. They also indicate that both p27 induction and cyclin A downregulation contribute to the inhibition of cdk2 and cell proliferation by cell-cell contact in ECs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712384     DOI: 10.1161/01.atv.20.3.629

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  11 in total

1.  VEGFR2 translocates to the nucleus to regulate its own transcription.

Authors:  Inês Domingues; José Rino; Jeroen A A Demmers; Primal de Lanerolle; Susana Constantino Rosa Santos
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

2.  Cytosolic phospholipase A2-alpha mediates endothelial cell proliferation and is inactivated by association with the Golgi apparatus.

Authors:  S P Herbert; S Ponnambalam; J H Walker
Journal:  Mol Biol Cell       Date:  2005-06-01       Impact factor: 4.138

Review 3.  Cell Cycle Progression and Synchronization: An Overview.

Authors:  Zhixiang Wang
Journal:  Methods Mol Biol       Date:  2022

4.  Endothelial injury induces vascular smooth muscle cell proliferation in highly localized regions of a direct contact co-culture system.

Authors:  Jeffrey G Jacot; Joyce Y Wong
Journal:  Cell Biochem Biophys       Date:  2008-09-03       Impact factor: 2.194

5.  Propranolol Decreases Proliferation of Endothelial Cells Transformed by Kaposi's Sarcoma-Associated Herpesvirus and Induces Lytic Viral Gene Expression.

Authors:  Shane C McAllister; Ryan S Hanson; Rory D Manion
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

6.  A VE-cadherin-PAR3-α-catenin complex regulates the Golgi localization and activity of cytosolic phospholipase A(2)α in endothelial cells.

Authors:  Adam F Odell; Monica Hollstein; Sreenivasan Ponnambalam; John H Walker
Journal:  Mol Biol Cell       Date:  2012-03-07       Impact factor: 4.138

7.  Identification of cyclins A1, E1 and vimentin as downstream targets of heme oxygenase-1 in vascular endothelial growth factor-mediated angiogenesis.

Authors:  Andrea Bauer; Hayley Mylroie; C Clare Thornton; Damien Calay; Graeme M Birdsey; Allan P Kiprianos; Garrick K Wilson; Miguel P Soares; Xiaoke Yin; Manuel Mayr; Anna M Randi; Justin C Mason
Journal:  Sci Rep       Date:  2016-07-08       Impact factor: 4.379

8.  The chemokine receptor CX3CR1 coordinates monocyte recruitment and endothelial regeneration after arterial injury.

Authors:  Tobias Getzin; Kashyap Krishnasamy; Jaba Gamrekelashvili; Tamar Kapanadze; Anne Limbourg; Christine Häger; L Christian Napp; Johann Bauersachs; Hermann Haller; Florian P Limbourg
Journal:  EMBO Mol Med       Date:  2018-02       Impact factor: 12.137

9.  Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation Assay.

Authors:  Lamis Hammoud; Jessica R Adams; Amanda J Loch; Richard C Marcellus; David E Uehling; Ahmed Aman; Christopher Fladd; Trevor D McKee; Christine E B Jo; Rima Al-Awar; Sean E Egan; Janet Rossant
Journal:  Stem Cell Reports       Date:  2016-09-08       Impact factor: 7.765

Review 10.  Developmental Perspectives on Arterial Fate Specification.

Authors:  Dongying Chen; Martin A Schwartz; Michael Simons
Journal:  Front Cell Dev Biol       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.